Pharmacokinetics/pharmacodynamics of gamithromycin for treating Pasteurella multocida infection in cattle using a tissue cage model
PLOS One · 2025
DOI: 10.1371/journal.pone.0323727 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Qingwen Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Veterinary Pharmacology, Department of Animal Science and Technology, Chongqing Three Gorges Vocational College, Chongqing, China. Hauptthemen laut MEDLINE: Pasteurella multocida, Pasteurella Infections, Anti-Bacterial Agents, Macrolides. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Research Program of Chongqing Municipal Education Commission.
Abstract (Originalsprache)
In this study, gamithromycin, a long-acting azalide antibiotic recently introduced for bovine respiratory disease (BRD) treatment, was evaluated for its effectiveness against Pasteurella multocida using a cattle tissue cage model. Gamithromycin (6 mg/kg) was administered via both intravenous and subcutaneous routes and the gamithromycin contents in sera, transudates, and exudates were measured using HPLC/MS-MS. Non-compartmental methods were utilized for assessing pharmacokinetic parameters and an inhibitory sigmoid E max model determined associations between the pharmacokinetic/pharmacodynamic (PK/PD) indices and antibacterial activity. The area under the 24-h concentration-time curve/minimum inhibitory concentration (AUC 0-24h /MIC) was found to be an optimal measure of antibacterial activity. The AUC 0-24h /MIC values over 24 h in sera, transudates, and exudates were 0.27, 0.17, and 0.14, respectively, for bacteriostatic effects, while for bactericidal activity, the AUC 0-24h /MIC values over 24 h in sera and exudates 3.76 and 5.31, respectively, and for bacterial eradication, the serum value was 18.46. These findings contribute valuable insights into the optimization of gamithromycin dosing regimens for treating respiratory conditions caused by Pasteurella multocida in cattle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratory of Veterinary Pharmacology, Department of Animal Science and Technology, Chongqing Three Gorges Vocational College, Chongqing, China.
- Heilongjiang Province Key Laboratory of Veterinary Drugs, Branch of Animal Husbandry and Veterinary of Heilongjiang Academy of Agricultural Sciences, Qiqihar, China.
- Qiqihar Senyu Environmental Protection Technology Co., Ltd, Qiqihar, China.
ORCID-Profile: Xuesong Liu
Förderung
- Science and Technology Research Program of Chongqing Municipal Education Commission
Zitieren
APA
Yang, Q., Liu, X., Lv, Y., & Li, Y. (2025). Pharmacokinetics/pharmacodynamics of gamithromycin for treating Pasteurella multocida infection in cattle using a tissue cage model. PLOS One. https://doi.org/10.1371/journal.pone.0323727
Vancouver
Yang Q, Liu X, Lv Y, Li Y. Pharmacokinetics/pharmacodynamics of gamithromycin for treating Pasteurella multocida infection in cattle using a tissue cage model. PLOS One. 2025. doi:10.1371/journal.pone.0323727
BibTeX
@article{Yang2025,
author = {Yang, Qingwen and Liu, Xuesong and Lv, Yongzhi and Li, Yushen},
title = {Pharmacokinetics/pharmacodynamics of gamithromycin for treating Pasteurella multocida infection in cattle using a tissue cage model},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0323727}
}
EUVIMED